Bupropion Hydrochloride Tablet
Product Images NDC 68001-613

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 68001-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion 150mg 30ct (Bupropion 150mg 30s)

Bupropion 150mg 30ct (Bupropion 150mg 30s)
This is a description of bupropion HCI Extended-Release Tablets, manufactured by Granules India Limited. The tablets are for BluePoint Laboratories and each tablet contains 150 mg of bupropion hydrochloride, USP. The usual dosage is one tablet daily or as directed by a physician. The medication guide is enclosed for proper dispensing. The tablets are only for prescription use and should be kept at controlled room temperature below 77°F. Additional medication guides are available online.*
FDA Label Image

Bupropion 300mg 30ct (Bupropion 300mg 30s)

FDA Label Image

Bupropion-structure.jpg (Bupropion Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.